Kamyar Arasteh
Kamyar Arasteh, PhD
NYU School of Global Public Health - Clinical Associate Professor
Research Interests
IDUs, Estonia, HCV, HIV risks


Arasteh K, Des Jarlais DC, Feelemyer J, McKnight C (2020).
Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City
Global Public Health [Epub 2020 May 19]. doi: 10.1080/17441692.2020.1768276.

Moles JP, Vallo R, Khue PM, Huong DT, Oanh KTH, Thoa NT, Giang HT, Thanh NTT, Vinh VH, Bui Thi TA, Peries M, Arasteh K, Quillet C, Feelemyer J, Michel L, Des Jarlais D, Laureillard D, Nagot N (2020).
HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam
Scientific Reports, 10 (1), 6999. doi: 10.1038/s41598-020-63990-w. PMCID: PMC7181676.

Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K (2020).
Expansion of syringe service programs in the United States, 2015-2018
American Journal of Public Health, 110 (4), 517-519. doi: 10.2105/AJPH.2019.305515. PMCID: PMC7067090.

Arasteh K, Des Jarlais DC, McKnight C, Feelemyer J (2019).
Injection and heterosexual risk behaviors for HIV infection among non-gay identifying men who have sex with men and women
AIDS and Behavior, 23 (12), 3315-3323. doi: 10.1007/s10461-019-02551-3.

Des Jarlais DC, Arasteh K, McKnight C, Feelemyer J, Perlman DC, Tross S (2019).
Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018
Drug and Alcohol Dependence, 204, 107459. doi: 10.1016/j.drugalcdep.2019.04.030. PMCID: PMC6878143.

Dr. Arasteh's Research Gate Profile